"Venrock Healthcare Leads €308 Million Series C Financing for Biotech Company Tubulis"

"YPOG has advised Venrock Healthcare Capital Partners on a successful €308 million Series C financing round for Tubulis, a biotech company based in Martinsried. This funding, one of the largest for a European biotech firm this year, will support the clinical development of Tubulis' lead antibody-drug conjugate candidate, TUB-040, aimed at treating ovarian and lung cancer, as well as expanding its pipeline and technology platforms. The round included participation from notable investors like Wellington Management and existing backers such as Nextech Invest and EQT Life Sciences."

**Law Firms Involved:** YPOG and the US law firm Cooley participated in the transaction, advising lead investor Venrock Healthcare Capital Partners. **Transaction Overview:** On October 20, 2025, YPOG announced its advisory role in the successful Series C financing round for Tubulis, a biotech company based in Martinsried. The financing round raised 308 million EUR (361 million USD), marking it as one of the largest private financing rounds for a European biotech company this year. The funds will primarily be used to accelerate the clinical development of Tubulis' lead antibody-drug conjugate (ADC) candidate, TUB-040, and to expand its pipeline and technology platforms. **Legal Team:** - Dr. Benjamin Ullrich (Lead, Transactions), Partner, Berlin - Stefan Richter (Tax), Partner, Hamburg - Dr. Benedikt Flöter (IP/IT/Data Protection), Partner, Berlin - Dr. Carolin Raspé (Corporate Crime + Compliance + Investigations), Partner, Munich - Dr. Emma Peters (Transactions), Associated Partner, Berlin - Tobias Lovett (Transactions), Associated Partner, Berlin - Pia Meven (Transactions), Associated Partner, Berlin - Anna Eickmeier (IP/IT/Data Protection), Senior Associate, Berlin - Theresia M.R. Heinrich (Transactions), Senior Associate, Berlin - Konstantina Nathanail (IP/IT/Data Protection), Associate, Berlin - Silke Ricken (Corporate), Associate, Berlin - Dr. Christian Busmann (Tax), Associate, Hamburg Cooley's team was led by James Schneider, Partner, Boston office.

"Venrock Healthcare Leads €308 Million Series C Financing for Biotech Company Tubulis"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads